Valuation (83%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 14.19 | N/A |
| PEG Ratio (TTM) | 0.73 | N/A |
| P/S Ratio (TTM) | 2.05 | N/A |
| P/B Ratio (TTM) | 1.29 | N/A |
| P/FCF Ratio (TTM) | 8.20 | N/A |
| Price to 5YR AVG Earnings Ratio | 14.27 | N/A |
| Price to 5YR AVG FCF Ratio | 12.87 | N/A |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.67% | N/A |
| ROE (TTM) | 9.57% | N/A |
| Net Profit Margin (TTM) | 14.59% | N/A |
| ROIC 5YR AVG | 14.67% | N/A |
Growth (70%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 27.83% | 14.42% | 3.57% |
| Revenue | 9.63% | 8.37% | 4.71% |
| Net Income | 27.63% | 14.30% | 3.69% |
| Cash Flow | 912.02% | 113.28% | 46.66% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | N/A |
| Quick Ratio (TTM) | N/A | N/A |
| D/E Ratio (TTM) | 0.45 | N/A |
| Interest Coverage (TTM) | 0.58 | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | 0.33 | N/A |
| LTL to 5YR AVG FCF | 1.29 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.03% | N/A |